血液透析患者的冠状动脉疾病:引起警报的问题
Simona Barbuto1,2, Lilio Hu1,2, Chiara Abenavoli1,2
1Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40126 Bologna, Italy.
Reviews in cardiovascular medicine
|July 30, 2024
概括
慢性病 (CKD) 显著增加心血管 (CV) 风险,特别是在末期病 (ESKD) 患者接受血液透析 (HD). 对于可靠的生物标志物和治疗方法来预测和管理这种人群中的CV事件,需要更多的研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 慢性病 (CKD) 的患病率正在全球范围内上升.
- 慢性病与不良结果密切相关,包括心血管 (CV) 事件和末期病 (ESKD).
- 血液透析 (HD) 的ESKD患者面临着复杂的CV挑战,这些挑战在研究中经常被忽视.
研究的目的:
- 审查有关ESKD患者心血管疾病 (CVD) 风险的当前文献.
- 评估ESKD中冠状动脉疾病 (CAD) 的诊断和治疗策略.
- 突出需要加强对HD患者的研究.
主要方法:
- 关于ESKD中心血管风险的重要文章的文献综述.
- 在ESKD中对CAD的诊断工具和治疗方法的数据进行推断.
- 分析血液透析在研究中的作用.
主要成果:
- 随着估计的膜过率 (eGFR) 的下降,CAD风险升级,在ESKD中达到顶峰.
- 存在各种诊断方法,包括实验室检测,心声学和血管成像,但在ESKD中缺乏明确的验证.
- 目前的治疗方法包括改变生活方式,药物和侵入性手术,对ESKD有效性的证据有限.
结论:
- 迫切需要进行强大的临床研究,以开发可靠的预后生物标志物,用于ESKD患者的CV和CAD风险.
- 血液透析为研究和患者监测提供了一个独特的环境,促进临床试验.
- 进一步的研究对于改善ESKD中CV事件的预防和治疗至关重要.
相关概念视频
Dialysis
286
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
286
Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77
Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Renal Corpuscle
1.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K


